For the complete version of this earnings report, please visit: www.genommalab.com
Genomma Lab Internacional, S.A.B. de C.V. is one of the fastest growing over-the-counter pharmaceutical and personal care products companies in Mexico. Genomma Lab develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share. Through a combination of a successful new products development process, consumer-oriented marketing, a broad retail distribution network and a low-cost, highly flexible operating model.
The Company had net sales of Ps. 2,629.4 million and EBITDA of Ps. 691.1 million in 2008. Genomma Lab's shares are listed on the Mexican Stock Exchange under the ticker symbol "LAB.B" (Bloomberg: labb.mx).
Note on Forward-Looking Statements
This report may contain certain forward-looking statements and information
relating to the Company that reflect the current views and/or expectations of
the Company and its management with respect to its performance, business and
future events. Forward-looking statements include, without limitation, any
statement that may predict, forecast, indicate or imply future results,
performance or achievements, and may contain words like "believe,"
"anticipate," "expect," "envisages," "will likely result," or any other words
or phrases of similar meaning. Such statements are subject to a number of
risks, uncertainties and assumptions. We caution you that a number of
important factors could cause actual results to differ materially from the
plans, objectives, expectations, estimates and intentions expressed in this
presentation and in oral statements made by
|SOURCE Genomma Lab Internacional, S.A.B. de C.V.|
Copyright©2009 PR Newswire.
All rights reserved